Adolescent Depression Clinical Trial
— AMPTOfficial title:
Probing the Neurophysiological Mechanisms Underlying Sex-specific Testosterone-mood Relationships During Puberty: A Randomized Controlled Trial Using a Smartphone-based Training Program
| NCT number | NCT06072677 |
| Other study ID # | 23-1336 |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | August 24, 2023 |
| Est. completion date | December 2027 |
Starting at puberty, female adolescents are nearly three-times more likely to develop internalizing disorders, like depression, while male adolescents are two-times more likely to develop externalizing disorders, like attention deficit hyperactivity disorder (ADHD). This divergence between the sexes during puberty suggests sex-specific pathways of risk and differential effects of sex hormones. The purpose of this research is to determine: 1) sex-specific neural and endocrine features of the pubertal transition that may mediate sex differences in adolescent mood disorders, and 2) the neurophysiological basis of susceptibility to hormone change during puberty.
| Status | Recruiting |
| Enrollment | 60 |
| Est. completion date | December 2027 |
| Est. primary completion date | December 2027 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 11 Years to 14 Years |
| Eligibility | Inclusion Criteria: - Between the ages of 11 and 14 - Have their own personal mobile device and capability to download the MyCap and Healthy Minds apps - Experienced a stressful life event within the last year, or endorse moderate depression (defined by a CES-DC score 16 or higher) Exclusion Criteria: - Previous experience with the Healthy Minds Program - Regular meditation practice - Current or history of manic episodes, psychotic symptoms, or current suicidal intent - Taking any form of exogenous hormones or intrauterine device (IUD) within one month of participation in the study - Taking medications that directly alter cardiovascular or neurological function |
| Country | Name | City | State |
|---|---|---|---|
| United States | Carolina Crossing B, Suite 1 | Chapel Hill | North Carolina |
| Lead Sponsor | Collaborator |
|---|---|
| University of North Carolina, Chapel Hill | Foundation of Hope, North Carolina |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | CES-DC Score Over Time | The 20-item Center for Epidemiological Studies Depression Scale for Children (CES-DC) will be the primary measure of severity of depressive symptoms. Each item is rated 0 (not at all) to 3 (a lot), with items 4, 8, 12, and 16 being reversed scored. The total CES-DC score may range from 0-60. Higher scores indicate more severe depressive symptoms. Scores of 15 or greater are suggestive of significant depressive symptoms. The overall CES-DC score will be assessed at the end of each week in the study. | up to Week 8 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00399776 -
Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy
|
N/A | |
| Completed |
NCT04603053 -
Determining Effectiveness of an mHealth Intervention to Provide Adolescent CBT
|
N/A | |
| Completed |
NCT01802437 -
An Adaptive Treatment Strategy for Adolescent Depression
|
Phase 1/Phase 2 | |
| Completed |
NCT06325605 -
Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression
|
N/A | |
| Completed |
NCT02017535 -
An Adaptive Treatment Strategy for Adolescent Depression-Continuation
|
Phase 1/Phase 2 | |
| Completed |
NCT03154008 -
Predictors of Response to Treatment for Depression
|
N/A | |
| Recruiting |
NCT04613453 -
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine
|
Phase 2 | |
| Terminated |
NCT00284791 -
Lamotrigine in Treatment Resistant Depression in Adolescents
|
N/A | |
| Completed |
NCT00312897 -
Omega-3 Fatty Acids in Adolescent Depression
|
Phase 2 | |
| Recruiting |
NCT01857518 -
Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study
|
N/A | |
| Recruiting |
NCT01170520 -
Repetitive Transcranial Stimulation (rTMS) for Resistant Depression in Adolescents
|
Phase 1/Phase 2 |